Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.

Saved in:
Bibliographic Details
Title: Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.
Authors: Nielsen CM; University of Oxford, Oxford, Oxfordshire, United Kingdom., Barrett JR; University of Oxford, Oxford, Oxfordshire, United Kingdom., Davis C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA., Fallon JK; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Goh C; University of Oxford, Oxford, Oxfordshire, United Kingdom., Michell AR; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Griffin C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA., Kwok A; University of Oxford, Oxford, Oxfordshire, United Kingdom.; Wellcome Center for Human Genetics, University of Oxford, Oxford, Oxfordshire, United Kingdom., Loos C; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA.; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Darko S; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Laboune F; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Tekman M; Institute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Diouf A; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA., Miura K; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA., Francica JR; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Ransier A; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Long CA; Laboratory of Malaria and Vector Research, NIAID/NIH, Rockville, Maryland, USA., Silk SE; University of Oxford, Oxford, Oxfordshire, United Kingdom., Payne RO; University of Oxford, Oxford, Oxfordshire, United Kingdom., Minassian AM; University of Oxford, Oxford, Oxfordshire, United Kingdom., Lauffenburger DA; Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA., Seder RA; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Douek DC; Vaccine Research Center, NIAID/NIH, Bethesda, Maryland, USA., Alter G; Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Boston, Massachusetts, USA., Draper SJ; University of Oxford, Oxford, Oxfordshire, United Kingdom.
Source: JCI insight [JCI Insight] 2023 Jan 24; Vol. 8 (2). Date of Electronic Publication: 2023 Jan 24.
Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.163859